Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous bone marrow MSC for acute ischemic stroke
ChiCTR-ONRC-14005040Phase 4Recruiting
- Sponsor
- Guangdong Sanjiu Brain Hospital
- Start
- Sep 2014
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 4, open-label trial of autologous bone-marrow mesenchymal stem cells in ischemic stroke (2 arms), sponsored by Guangdong Sanjiu Brain Hospital. Primary endpoints: MRI score, NIHSS score and 1 more. Started Sep 2014; status: recruiting.
02
Drugs
autologous bone-marrow mesenchymal stem cells
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR-ONRC-14005040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONRC-14005040.